Results 161 to 170 of about 39,459 (248)

Limited scleroderma with pauci-immune glomerulonephritis in the presence of renal cell carcinoma. [PDF]

Clin Med Res, 2013
Abrich V, Duvuru S, Swanson HJ.
europepmc   +1 more source

Cytometry-based blood immune cell markers associated with clinical outcomes in systemic sclerosis: protocol for a systematic review. [PDF]

BMJ Open
Souffez M, Dumontet E, Lecureur V, Lescoat A, Ferrant J.   +4 more
europepmc   +1 more source

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review. [PDF]

Pediatr Rheumatol Online J
Zheng R, Zou L, Li SC, Lu M.
europepmc   +1 more source

Prevalence and severity of complicated Raynaud's phenomenon in limited and diffuse systemic sclerosis: a multicenter study in Iraq. [PDF]

Reumatologia
Jaafar F, Moayad Z, Gorial F, Alkazzaz A.   +3 more
europepmc   +1 more source

Evaluating context effects on PHQ-8 somatic item scores among people with a chronic medical condition: a scleroderma patient-centred intervention network randomised experiment. [PDF]

Epidemiol Psychiatr Sci
Hu S, Carrier ME, Golberg M, Geoffroy MC, Kwakkenbos L, Bartlett SJ, Fortuné C, Gietzen A, Gottesman K, Lawrie-Jones A, Malcarne VL, Richard M, Sauvé M, Mouthon L, Benedetti A, Thombs BD, SPIN Investigators.   +16 more
europepmc   +1 more source

Scleroderma renal crisis: avoiding the diagnostic pitfalls of an elusive condition. [PDF]

Rheumatol Adv Pract
Ng IKS, Tang MS, See FH, Cho J.
europepmc   +1 more source

PD-1 inhibitor-induced systemic sclerosis with early interstitial lung disease and autoimmune thyroiditis in advanced gastric cancer: a case report and literature review. [PDF]

Front Oncol
Lyu Q, Xu X, She W, Wang J, Aimurula M, Zhou M, Ding J, Gu Y.   +7 more
europepmc   +1 more source

Immune checkpoint inhibitor-associated scleroderma refractory to corticosteroids: Clinical improvement with intravenous immune globulin and dupilumab. [PDF]

JAAD Case Rep
Abul-Enin DG, Edmonds NL, Rusu CA.
europepmc   +1 more source

Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation. [PDF]

Front Pharmacol
Khan MA, Koniyan S, Ahir M, Jegga AG, Mayes MD, Gius D, Leung J, Bonnen MD, Montesi SB, Ghebre YT.   +9 more
europepmc   +1 more source

Anxiety symptoms and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a cross-sectional study. [PDF]

Rheumatology (Oxford)
Provencher S, Carrier ME, Virgili-Gervais G, Golberg M, Henry RS, Kwakkenbos L, Fortuné C, Gietzen A, Gottesman K, Guillot G, Lawrie-Jones A, Sauvé M, Bartlett SJ, Hummers LK, Malcarne V, Mayes MD, Richard M, Stempel J, Wojeck RK, Mouthon L, Benedetti A, Thombs BD, Scleroderma Patient-centered Intervention Network Investigators .   +22 more
europepmc   +1 more source